口服氯胺酮可改善肠易激综合征的症状

Omar Dyara, Natasha Topoluk, Harvey J Woehlck
{"title":"口服氯胺酮可改善肠易激综合征的症状","authors":"Omar Dyara, Natasha Topoluk, Harvey J Woehlck","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Irritable bowel syndrome (IBS) often is treated as a partially diet-responsive functional bowel disorder. Few interventions have been found to be effective in diet-refractory IBS, leading to lifestyle disruptions due to persistent symptoms. The efficacy of low-dose home ketamine therapy suggests others may benefit.</p><p><strong>Case presentation: </strong>A female patient in her 60s with progressive presumed IBS with diarrhea found diet-based treatments ineffective, resulting in severe lifestyle disruptions. After a hysterectomy, intolerance to opioids for postoperative pain prompted the use of intravenous ketamine. An unexpected and prolonged improvement in IBS symptoms resulted. The patient sought continued treatment with ketamine for IBS symptoms and experienced continued symptomatic relief with 20 mg oral ketamine every 2 weeks at home.</p><p><strong>Discussion: </strong>No other published cases of ketamine for IBS were found.</p><p><strong>Conclusions: </strong>While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.</p>","PeriodicalId":94268,"journal":{"name":"WMJ : official publication of the State Medical Society of Wisconsin","volume":"123 5","pages":"384-386"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.\",\"authors\":\"Omar Dyara, Natasha Topoluk, Harvey J Woehlck\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Irritable bowel syndrome (IBS) often is treated as a partially diet-responsive functional bowel disorder. Few interventions have been found to be effective in diet-refractory IBS, leading to lifestyle disruptions due to persistent symptoms. The efficacy of low-dose home ketamine therapy suggests others may benefit.</p><p><strong>Case presentation: </strong>A female patient in her 60s with progressive presumed IBS with diarrhea found diet-based treatments ineffective, resulting in severe lifestyle disruptions. After a hysterectomy, intolerance to opioids for postoperative pain prompted the use of intravenous ketamine. An unexpected and prolonged improvement in IBS symptoms resulted. The patient sought continued treatment with ketamine for IBS symptoms and experienced continued symptomatic relief with 20 mg oral ketamine every 2 weeks at home.</p><p><strong>Discussion: </strong>No other published cases of ketamine for IBS were found.</p><p><strong>Conclusions: </strong>While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.</p>\",\"PeriodicalId\":94268,\"journal\":{\"name\":\"WMJ : official publication of the State Medical Society of Wisconsin\",\"volume\":\"123 5\",\"pages\":\"384-386\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"WMJ : official publication of the State Medical Society of Wisconsin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"WMJ : official publication of the State Medical Society of Wisconsin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导言:肠易激综合征(IBS)通常被视为一种对饮食有部分反应的功能性肠道疾病。很少有干预措施对饮食难治性肠易激综合征有效,这导致患者因症状持续存在而影响生活方式。低剂量家庭氯胺酮疗法的疗效表明,其他人也可能从中受益:一位 60 多岁的女性患者患有进行性推测肠易激综合征并伴有腹泻,但发现基于饮食的治疗无效,导致生活方式受到严重影响。子宫切除术后,由于不耐受阿片类药物的术后疼痛,她开始静脉注射氯胺酮。结果,肠易激综合征症状得到了意想不到的长期改善。患者寻求继续使用氯胺酮治疗肠易激综合征症状,每两周在家中口服20毫克氯胺酮,症状得到持续缓解:讨论:没有发现其他公开发表的氯胺酮治疗肠易激综合征的病例:结论:虽然改变饮食仍然是治疗肠易激综合征的黄金标准,但该患者的经历突出表明氯胺酮是一种潜在的辅助疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.

Introduction: Irritable bowel syndrome (IBS) often is treated as a partially diet-responsive functional bowel disorder. Few interventions have been found to be effective in diet-refractory IBS, leading to lifestyle disruptions due to persistent symptoms. The efficacy of low-dose home ketamine therapy suggests others may benefit.

Case presentation: A female patient in her 60s with progressive presumed IBS with diarrhea found diet-based treatments ineffective, resulting in severe lifestyle disruptions. After a hysterectomy, intolerance to opioids for postoperative pain prompted the use of intravenous ketamine. An unexpected and prolonged improvement in IBS symptoms resulted. The patient sought continued treatment with ketamine for IBS symptoms and experienced continued symptomatic relief with 20 mg oral ketamine every 2 weeks at home.

Discussion: No other published cases of ketamine for IBS were found.

Conclusions: While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信